Japan Synthetic Biology Trends And Forecasts Report 2026: A $5.74 Billion Market By 2040, Driven By Increased Demand For Bio-Products And Advances In CRISPR And DNA Synthesis

(MENAFN- GlobeNewsWire - Nasdaq) Japan's synthetic biology market is poised for growth due to increased demand for bio-products and advances in CRISPR and DNA synthesis. Key opportunities lie in healthcare, agriculture, and sustainable solutions. The market challenges include high costs, regulatory hurdles, and talent shortages yet academic growth and strategic R&D boost potential.

Dublin, March 03, 2026 (GLOBE NEWSWIRE) -- The "Japan Synthetic Biology Market, till 2035: Industry Trends and Global Forecasts - Distribution by Type of Product, Type of Tool, Type of Technology, Type of Application, End User and Leading Players" report has been added to ResearchAndMarkets's offering.
The Japan synthetic biology market is estimated to grow from USD 0.79 billion in the current year to USD 5.74 billion by 2040 at a CAGR of 15.7% during the forecast period, 2026-2040.

Japan holds a prominent position in the Asia-Pacific synthetic biology market due to its advanced R&D ecosystem and strategic investments. In addition, several factors contribute to higher market share compared to other regions. Further, health-conscious consumers are driving the demand for sustainable bio-products, such as personalized medicines and eco-materials, amplified by Japan's manufacturing strength and trade partnerships. These elements position Japan as a mature hub amid demographic and cost challenges.
The ongoing shift towards biofuels or green fuels and the demand for sustainable or biodegradable products have further fueled market expansion. As synthetic biology technologies mature across various industrial sectors, they are paving the way for the production of sustainable bio-based solutions. In addition, advancements in synthetic biology are broadening their applications as tools for writing, reading, and editing DNA in organisms to produce valuable commodities.
Genomatica has successfully developed a microorganism-based production method (Geno proprietary technology) that transforms renewable sugars from plants into precursors for nylon (100% renewable carbon-sourced nylon-6). The agriculture sector has also seen a rising implementation of synthetic biology for research and development purposes. For instance, Rice University established the Rice Synthetic Biology Institute to foster collaborative research in synthetic biology and translate it into advantageous technologies.
Alongside the increased utilization of synthetic biology in various fields, the high demand for early disease detection and treatment is propelling research and development in advanced genetic technologies. It is worth highlighting that the growing focus on cancer treatment research has promoted the use of synthetic biology.

This technology is instrumental in producing enabling products, including glutaminase, arginase, oxidase, dehydrogenase, deiminase, and ribonuclease, which serve as essential components in the evaluation of cancer-causing cells and in the creation of therapies. Given these trends, we anticipate that the synthetic biology market will experience substantial growth throughout the forecast period.
Growth Drivers: Strategic Enablers of Market Expansion
Advancements in CRISPR technology and DNA synthesis are decreasing costs and enhancing accuracy in biological engineering. There is a rising need for bio-derived fuels, materials, and therapeutics as part of decarbonization initiatives, backed by robust academic research and global collaborations. Government regulations and Japan's proficiency in precision engineering are also driving the adoption in the healthcare and manufacturing sectors.
Market Challenges: Critical Barriers Impeding Progress
The expensive nature of platforms and bioprocessing obstructs scaling up, especially for intricate therapies. Regulatory challenges concerning engineered organisms, along with ethical and biosafety issues, delay the arrival of products to the market. A lack of skilled talent in various fields and pushback from conventional industries create obstacles for broader adoption of synthetic Biology in Japan.
Polymerase Chain Reaction (PCR): Leading Market Segment
In terms of type of technology, the Japan synthetic biology market is segmented across PCR Technology, NGS technology, genome editing technology, bioprocessing technology and other technologies. Currently, polymerase chain reaction (PCR) segment captures around 30% of the overall market share, due to its precision, rapidity, and extensive use in identifying infectious diseases, genetic conditions, and cancer. However, the genome editing technology segment is likely to grow at a higher CAGR of 16.6% during the forecast period, which is probably influenced by its capacity to deliver detailed genomic data and sophisticated personalized medical care.
Oligonucleotide / Oligo Pools and Synthetic DNA: Dominating Market Segment
In terms of type of product, the Japan synthetic biology market is segmented across oligonucleotide / oligo pools and synthetic DNAdna, enzymes, cloning technologies kits, chassis organism, and others. Currently, majority (~30%) of the market share is held by oligonucleotide / oligo pools and synthetic DNA. This can be linked to the collection of blood, serum, and plasma in clinical environments, which facilitates large-scale testing and ongoing observation. Additionally, the urine segment is expected to experience a higher compound annual growth rate (CAGR) of 7.1% throughout the forecast period.
Academic and Government Research Institutes: Emerging Market Segment
In terms of end-users, the Japan synthetic biology market is segmented across biotechnology and pharmaceutical companies, academic and government research institutes and others. Currently, majority (~70%) of the market share is held by biotechnology and pharmaceutical companies. However, Academic and Government Research Institutes are anticipated to grow at a higher CAGR of 16.1%.

KEY QUESTIONS ANSWERED IN THIS REPORT

• How many synthetic biology solution providers are currently engaged in this market?
• Which are the leading companies in this market?
• Which country dominates the Japan synthetic biology market?
• What are the key trends observed in the Japan synthetic biology market?
• What factors are likely to influence the evolution of this market?
• What are the primary challenges faced by synthetic biology solution providers in Japan?
• What is the current and future Japan synthetic biology market size?
• What is the CAGR of Japan synthetic biology market?
• How is the current and future market opportunity likely to be distributed across key market segments?

COMPANY PROFILES: JAPAN SYNTHETIC BIOLOGY MARKET

• Amyris
  • Company Overview
  • Product Portfolio
  • Financial Information
  • Recent Developments and Future Outlook
• Bruker Cellular Analysis
• Bico
• Codexis
• Ginkgo Bioworks
• GenScript Biotech
• Integrated DNA Technologies
• Insitro
• Novozymes
• Zymergen

JAPAN SYNTHETIC BIOLOGY MARKET: KEY SEGMENTS

Type of Product

• Core Products
• Enabling Products

Type of Tool

• Oligonucleotides and Synthetic DNA
• Enzymes
• Cloning Technology Kits
• Synthetic Cells

Type of Technology

• Gene Synthesis
• Genome Engineering
• Microfluidics
• Nanotechnology
• Sequencing
• Bioinformatics
• Site-Directed Mutagenesis
• Cloning
• Measurement and Modeling
• Polymerase Chain Reaction

Type of Application

• Healthcare
• Artificial Tissue & Tissue Regeneration
• Industrial
• Environmental
• Food
• Agriculture

End User

• Biotechnology and Pharmaceutical companies
• Academic and Research Institutes
• Other End Users

COMPLEMENTARY BENEFITS

• Complimentary Excel Data Packs for all Analytical Modules in the Report
• 15% Free Content Customization
• Detailed Report Walkthrough Session with the Research Team
• Free Updated report if the report is 6-12 months old or older

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN03032026004107003653ID1110811273